Axplora’s Leverkusen site was awarded Platinum, with Le Mans receiving Gold, and Pompey
Highly potent drugs now account for over 30% of the global pipeline, with more
18 February, 2026 – Axplora, a global CDMO Partner for complex small molecules and antibody-drug
Axplora, a global leader in API small molecule and ADC (antibody-drug conjugate) manufacturing, is strengthening its leading position in the commercial manufacturing of ADCs with the launch of a cutting-edge payload manufacturing workshop at its Le M
